Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer’s disease not affected by co-administration of memantine: An open-label, crossover, single-centre study - Shua-Haim, J; Smith, J; Picard, F (Clin Drug Investig, 2008)
et al.